Topical calcipotriol (MC 903) for psoriasis: a clinical study
DOI:
https://doi.org/10.2340/00015560186169170Abstract
Calcipotriol, a non-calcemic vitamin D3 analogue, inhibits the proliferation and is necessary for final differentiation of keratinocytes. The aim of the present study was to determine the efficacy and tolerability of calcipotriol ointment in patients treated for 6 weeks. Twenty patients with chronic plaque-type psoriasis were treated twice daily with calcipotriol ointment 50 ng/g. After 6 weeks´ treatment there was a marked and statistically significant decrease in the PASI score values for 17 patients, no improvement was seen in 1 patient and local adverse events occurred in 2. Hypercalcemia or other laboratory abnormalities did not develop in any patient.Downloads
Download data is not yet available.
Downloads
Published
1994-02-01
How to Cite
Mozzanica, N., Cattaneo, A., Schmitt, E., Legori, A., & Finzi, A. (1994). Topical calcipotriol (MC 903) for psoriasis: a clinical study. Acta Dermato-Venereologica, 74, 169–170. https://doi.org/10.2340/00015560186169170
Issue
Section
Articles
License
LicenseAll digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
